The effectiveness of a real life dose reduction strategy for tumour necrosis factor inhibitors in ankylosing spondylitis and psoriatic arthritis
Warren Fong, Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Elaine Dennison(MRC Lifecourse Epidemiology Unit), Chris Holroyd(University Hospital Southampton NHS Foundation Trust), Cyrus Cooper(University Hospital Southampton NHS Foundation Trust), Brian Davidson(University Hospital Southampton NHS Foundation Trust), Ray Armstrong(University Hospital Southampton NHS Foundation Trust)
Cited by 27
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k